Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Basit Öğe Kaydı
dc.contributor.authorOzbalak, Murat
dc.contributor.authorAkay, Olga Meltem
dc.contributor.authorPehlivan, Mustafa
dc.contributor.authorYildiz, Birol
dc.contributor.authorUzay, Ant
dc.contributor.authorYigenoglu, Tugce Nur
dc.contributor.authorElverdi, Tugrul
dc.date.accessioned2024-04-24T17:50:03Z
dc.date.available2024-04-24T17:50:03Z
dc.date.issued2021
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS369en_US
dc.identifier.issn2152-2650
dc.identifier.issn2152-2669
dc.identifier.startpageS368en_US
dc.identifier.urihttps://hdl.handle.net/11468/23185
dc.identifier.volume21en_US
dc.identifier.wosWOS:000691910500283
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherCig Media Group, Lpen_US
dc.relation.ispartofClinical Lymphoma Myeloma & Leukemia
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRelapsed And Refractoryen_US
dc.subjectHodgkin Lymphomaen_US
dc.subjectBrentuximab Vedotinen_US
dc.subjectAutologous Stem Cell Transplantationen_US
dc.subjectConsolidationen_US
dc.titleBrentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Studyen_US
dc.titleBrentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu